TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Apr 14, 2021 13:49 JST
Source:
Eisai
Eisai to Present Latest Data on Neurology Products and Pipelines at the American Academy of Neurology Annual Meeting
TOKYO, Apr 14, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that the company will conduct presentations, including the latest data of the investigational anti-amyloid beta (Abeta) protofibril antibody lecanemab (development code: BAN2401), its dual orexin receptor antagonist lemborexant (product name: Dayvigo) and its antiepileptic drug perampanel (product name: Fycompa), at the Virtual American Academy of Neurology (AAN 2021) Annual Meeting from April 17 to 22, 2021.
As major presentations, an oral presentation regarding lecanemab will be given on the preliminary analysis for results of changes in brain-A beta levels and amyloid-related imaging abnormalities-edema (ARIA-E) as observed in subjects of the ongoing open-label extension of the Phase II study (Study 201) for early Alzheimer's disease (AD) patients. Poster presentations regarding lemborexant are also planned, including the results of a pilot study evaluating next-dose transition from zolpidem to lemborexant for insomnia treatment. Additionally, for perampanel, a global pooled analysis results from the real-world experiences including early adjunctive use or monotherapy will be presented at poster sessions.
Eisai considers neurology a therapeutic area of focus. Eisai strives to create innovative products in therapeutic areas with high unmet medical needs as soon as possible, and will further contribute to addressing the diverse needs of, as well as increasing the benefits provided to, those living with the disease and their families.
For more information, visit
https://www.eisai.com/news/2021/news202127.html
.
Source: Eisai
Sectors: BioTech
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference(R) 2026 (AAIC(R))
July 02 2026 21:45 JST
UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases
July 02 2026 21:01 JST
Eisai Announces Strategic Investment Supported by the UK Government's LSIMF
June 17 2026 12:28 JST
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 21 2026 23:23 JST
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
April 21 2026 19:52 JST
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
March 27 2026 19:14 JST
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
March 27 2026 17:19 JST
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
March 23 2026 10:19 JST
Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)
March 19 2026 09:54 JST
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
March 17 2026 18:49 JST
More Press release >>
Latest Press Release
JCB, Resona and ODAWARA MOU to Advance Hands-Free UWB Payments for a Next-Generation Bus Experience
Jul 09, 2026 10:00 JST
MUFG Bank and JCB Sign MOU for Comprehensive Strategic Alliance in ASEAN
Jul 06, 2026 13:30 JST
MHI Receives Order from Taiwan High Speed Rail Corporation for Maintenance Tools and Equipment for Yanchao Main Workshop
Jul 03, 2026 00:22 JST
Hitachi Rail completes acquisition of Clever Devices, expanding its portfolio of multi-modal transport solutions
Jul 02, 2026 23:15 JST
Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference(R) 2026 (AAIC(R))
Jul 02, 2026 22:45 JST
UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases
Jul 02, 2026 22:01 JST
Fujitsu Group achieves gold medal in EcoVadis sustainability rating
Jul 02, 2026 15:00 JST
NEC drives digital transformation at Messer Gases in Brazil with Cisco advanced networking and security solutions
Jul 02, 2026 15:00 JST
JCB Contactless Payment Now Available on Taipei Metro
Jul 01, 2026 10:00 JST
Hitachi High-Tech opens Innovation Center Eindhoven in the Netherlands to accelerate open innovation
Jul 01, 2026 00:59 JST
Honda to Commemorate 40th Anniversary of Its First F1(TM) Title
Jul 01, 2026 00:48 JST
Honda Issues "Honda ESG Report 2026"
Jul 01, 2026 00:24 JST
Sharp Signs Memorandum of Understanding with Major Global Satellite Operator SES to Build a Collaboration in Satellite Communication Services
Jul 01, 2026 00:09 JST
Mitsubishi Motors to Bring Authentic Off-Road Performance to Life with its All-New Pajero Cross-Country SUV
Jun 30, 2026 23:46 JST
MHIEC Completes Rebuild of Nagasaki City East Plant
Jun 30, 2026 23:04 JST
NEC Recognized as a Specialist in Gartner(R) Emerging Market Quadrant for Physical AI Services - Established Vendors
Jun 30, 2026 22:47 JST
DENSO and TUV Rheinland Japan Confirm the Practicality of Battery Passport for AESC's Energy Storage Product Using Actual Data
Jun 30, 2026 22:10 JST
Mitsubishi Shipbuilding Receives Order for the MAmmoSS(R) Ammonia Fuel Handling System
Jun 27, 2026 13:16 JST
MHI Study Results Indicate Potential Cost Reductions in the Decarbonization Value Chain Using Green Hydrogen and Ammonia Produced in India
Jun 27, 2026 13:00 JST
Foxconn and Sharp Signs Memorandum of Understanding for Strategic Collaboration in New Business Areas
Jun 27, 2026 12:44 JST
More Latest Release >>